Mizuho assumed coverage on shares of Vigil Neuroscience (NASDAQ:VIGL – Get Rating) in a research note released on Thursday morning, The Fly reports. The brokerage issued a buy rating and a $15.00 price objective on the stock. Other research analysts also recently issued reports about the company. Morgan Stanley upped their price objective on Vigil […]